Since our group previously discovered that T2D-RBCs induce endothelial dysfunction via upregulation of arginase-1 and increased formation of ROS, we hypothesized that arginase-1 and ROS are key players in the endothelial dysfunction triggered by T2D RBC-EVs. The gene discussed is ARG1; the disease is endothelial dysfunction.